Compound atlas
Healing

Thymosin α1

Also known as · Tα1 · Zadaxin

Half-life
2h
approx. mean t½
Dose range
1.6 mg / 2× week
typical, not prescriptive
Category
Healing
primary use-case
Overview

An immunomodulatory peptide. Approved in many countries for chronic hepatitis B and as cancer adjuvant. Off-label for immune support.

Mechanism of action

Activates T-cell maturation. Enhances dendritic cell function and Th1 response.

Typical protocol

1.6 mg subQ, 2× weekly. Cycles of 4–12 weeks.

Storage

Refrigerated reconstituted, ~14 days.

Disclaimer

This page summarizes publicly available information. None of it constitutes medical advice, prescription, or recommendation to acquire, possess, or use any compound. Many peptides described are research chemicals not approved for human use in the EU. Consult a licensed physician.